Literature DB >> 2841118

Nuclear factors in human brain cells bind specifically to the JCV regulatory region.

K Khalili1, J Rappaport, G Khoury.   

Abstract

The human polyomavirus, JCV, differs from other papovaviruses in its tissue tropism for human glial cells. Transcription of the early region of the virus, at least in part, contributes to the tissue specificity of JCV. In this study, we have synthesized oligonucleotides which span the JCV 98 bp repeat unit. Using gel mobility shift and UV cross-linking assays, we have demonstrated that four proteins from a human fetal brain extract interact specifically with the JCV promoter/enhancer. Two proteins of 82 kd and 78/80 kd recognize the 5'- and 3'-terminal regions of the JCV 98 bp repeat sequence, respectively. The mol. wt of these proteins are similar in HeLa and brain extracts. In contrast, the proteins which recognize the central region of the 98 bp enhancer are distinct in HeLa (85 kd) and fetal brain (45 kd) extracts. The possible role of these proteins in tissue-specific expression of the JCV early promoter in brain cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841118      PMCID: PMC454457          DOI: 10.1002/j.1460-2075.1988.tb02932.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

2.  Gene expression in rat brain.

Authors:  R J Milner; J G Sutcliffe
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

3.  Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements.

Authors:  F G Falkner; H G Zachau
Journal:  Nature       Date:  1984 Jul 5-11       Impact factor: 49.962

4.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene.

Authors:  D Picard; W Schaffner
Journal:  Nature       Date:  1984 Jan 5-11       Impact factor: 49.962

7.  A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome.

Authors:  F Strauss; A Varshavsky
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

8.  A Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity.

Authors:  C S Parker; J Topol
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

9.  Specific interaction between enhancer-containing molecules and cellular components.

Authors:  H R Schöler; P Gruss
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

10.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  25 in total

1.  Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma.

Authors:  A Rencic; J Gordon; J Otte; M Curtis; A Kovatich; P Zoltick; K Khalili; D Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

3.  Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.

Authors:  Kate Manley; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  Virology       Date:  2007-06-06       Impact factor: 3.616

4.  Enhancer/promoter activities of regulatory regions of representative JC virus isolates.

Authors:  J D Martin; P Li
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Regulation of a human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98 bp enhancer promoter region.

Authors:  S Ahmed; M Chowdhury; K Khalili
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

6.  Analysis of transcription control elements of the mouse myelin basic protein gene in HeLa cell extracts: demonstration of a strong NFI-binding motif in the upstream region.

Authors:  T Tamura; M Miura; K Ikenaka; K Mikoshiba
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

7.  An RNA-protein contact determined by 5-bromouridine substitution, photocrosslinking and sequencing.

Authors:  M C Willis; K A LeCuyer; K M Meisenheimer; O C Uhlenbeck; T H Koch
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

8.  Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells.

Authors:  R P Mayreddy; M Safak; M Razmara; P Zoltick; K Khalili
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus.

Authors:  H Tada; K Khalili
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.

Authors:  J Remenick; M F Radonovich; J N Brady
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.